Others have shown that, while inhibition of BCL-2 family proteins can significantly induce MCC cell death [43], BCL-2 antisense therapy alone was insufficient to inhibit tumor growth in patients with advanced MCC [33]). Here, BCL2 is linked to neoplasm.